BUY SIDE BRO

Mastercard Incorporated MA

Latest Deep Dive · Written · AI research note

Bro's Verdict
Deep Dive

Rating

HOLD

Confidence

68%

Target Price

$650.00

Upside

+9.2%

Horizon

medium

Mastercard is a best-in-class compounder with 61% operating margins and 15.7% forward EPS growth, but at 29.8x NTM P/E the valuation already reflects solid execution with limited margin of safety. The analyst rates the stock a Hold with a $650 target, implying roughly 9% upside, as the US debit routing and interchange litigation overhang caps multiple expansion. Accumulation is recommended only on a pullback toward $550, where risk/reward improves against the two-year average EV/EBIT anchor.

Executive Summary

•MA trades at $595, 29.8x NTM P/E against 15.7% forward EPS growth (PEG ~1.9x), a premium underwritten by best in class economics: 61.1% operating margin and 46.3% net margin.
•Value added services and new flows are the structural growth engine, underpinning 12.6% NTM revenue growth to $37.27b as mix shifts away from core network fees.
•The US debit routing and interchange litigation overhang is the dominant tail risk, with no clean visibility on timing or quantum.
•Insider activity skews negative into the 29 October Q3 print: 32 open market sells, zero buys, and $27.9m divested by the CEO.

Financial Snapshot

•Revenue TTM: $35.08b
•Net income TTM: $16.26b
•Operating margin: 61.1%
•Net margin: 46.3%
•Gross margin: 100% (network model, no cost of goods)
•ROE: 241.2% (flattered by a small equity base)
•Debt/Equity: 439.6% (accounting artefact of aggressive buybacks, not leverage stress)
•Latest quarter revenue: $9.28b
•Latest quarter net income: $4.39b
•Trailing four quarter revenue range: $8.40b to $9.28b
•Trailing four quarter net income range: $3.88b to $4.39b

Forward Outlook

•NTM revenue estimate: $37.27b (+12.6% YoY)
•NTM EPS estimate: $19.95 (+15.7% forward growth)
•FY+2 revenue estimate: $41.96b (+12.6% vs NTM)
•FY+2 EPS estimate: $23.09 (+15.7% vs NTM)
•Consensus NTM EPS revision snapshot: $22.36 (above the $19.95 base, discrepancy flagged, methodology not disclosed)
•Analyst coverage: 24 estimates, tight dispersion
•Margin trajectory: operating margin expected to hold above 60%, with operating leverage from value added services scaling faster than incentives
•Cross border volume growth: Not disclosed at segment level, but the key swing factor for travel linked revenue
•New flows and value added services mix: Not disclosed as a standalone forward line

Valuation Analysis

•NTM P/E: 29.83x (forward)
•NTM P/S: 13.99x (forward)
•NTM EV/EBIT: ~24x (estimated, EV ~$540b on ~$23b NTM EBIT)
•BF P/E: 26.5x vs 2y avg 29.1x (-9%, -0.4 SD, n=59)
•BF EV/EBITDA: 20.9x vs 2y avg 21.1x (-1%, flat on SD)
•BF EV/EBIT: 21.9x vs 2y avg 22.6x (-3%, -0.1 SD)
•BF EV/Rev: 13.0x vs 2y avg 12.4x (+5%, +0.2 SD)
•LF P/BV: 93.0x vs 2y avg 38.4x (+142%, +2.5 SD, distorted by buybacks, not a usable signal)
•Implied price at 2y avg P/E: $652.10
•Implied price at 2y avg EV/EBITDA: $598.93
•Implied price at 2y avg EV/EBIT: $615.32
•Implied price at 2y avg EV/Rev: $567.20
•Consensus price target: $668.67 (+12.4% upside), median $670, range $597 to $740
•Sell side ratings: 52 Buy / 13 Hold / 0 Sell

Peer Comparison

•V: ~33.1x TTM P/E, $730.8b market cap, direct network duopoly, richer multiple
•AXP: ~18.9x TTM P/E, $210.4b market cap, closed loop premium and lending exposure
•PYPL: ~10.6x TTM P/E, $48.3b market cap, checkout and branded button, value trap risk
•MA screens mid pack on trailing P/E, at a discount to V but a premium to AXP and PYPL on quality adjusted economics

Key Risks & Catalysts

Risks

•US debit routing and interchange litigation could force structural pricing changes
•Global regulatory pressure on interchange and network fees across jurisdictions
•Insider selling: 32 open market sells, zero buys, net -$40.1m over 90 days
•Premium multiple leaves limited margin of safety if growth decelerates
•Stablecoin rails and agentic commerce could disintermediate card networks over time
•Cross border travel weakness would hit the highest margin revenue line
•Consumer spend softness in lower ticket discretionary categories

Catalysts

•Q3 2026 earnings on 29 October, first read on cross border resilience
•Value added services and new flows revenue mix shift accelerating
•Continued tokenization penetration lifting authorisation rates
•Stablecoin and agentic commerce positioning announcements
•Ongoing buyback support compressing share count
•Consensus target of $668.67 implies re rating toward 2y average multiples

Investment Thesis

Mastercard is a high quality compounder trading at a full but defensible multiple. At $595, the stock sits at 29.8x NTM P/E for 15.7% forward EPS growth, a PEG near 1.9x that only makes sense because the business converts roughly 46 cents of every revenue dollar into net income and generates returns on equity above 200%. The relative valuation work is constructive: on backward looking P/E the shares trade 9% below the two year average, and mean reversion alone implies $652. The EV/EBIT and EV/EBITDA frameworks cluster around $599 to $615, suggesting the market is already pricing in solid execution with little room for error.

The forward story rests on mix shift. Core network fees grow roughly in line with nominal spend, but value added services and new flows are scaling faster and carry the growth burden as the company diversifies beyond interchange. Cross border volume remains the highest quality revenue line and the key swing factor into the 29 October print; any travel linked softness would pressure both growth and margin. The regulatory overhang from US debit routing and interchange litigation is the single largest unknown and caps multiple expansion until there is clarity.

We rate MA a Hold with a 12 month price target of $650, roughly the two year average P/E implied level and modestly below the $668.67 consensus. The thesis is quality at a fair price, not deep value. Accumulate on any pullback toward $550, where the risk reward improves materially against a 2y average EV/EBIT anchor. The insider selling pattern and the litigation overhang argue for patience rather than chasing the 52 week high.

Written by Buy Side Bro's AI analyst from financials, consensus, filings and recent news. General information only, not financial advice.

Run your own analysis free

Buy Side Bro writes a note like this on any US, ASX or global stock in a few minutes: the thesis, valuation, catalysts, risks and a Buy, Hold or Sell call with a 12-month target. It comes with the daily market wrap, live markets, earnings and charts. Sign in and you get 7 days of full access free, no card needed.

iPhone app coming soon. The same account and subscription carry over.

See the latest research on other stocks